The present invention discloses compounds of formula (I), and tautomeric forms, pharmaceutically acceptable salts, or solvates thereof. Preferably, the compounds of the invention are dual activators of hPPARη and hPPARα.
本发明揭示了公式(I)的化合物,以及其互变异构体、药学上可接受的盐或溶剂。优选地,本发明的化合物是h
PPARη和h
PPARα的双激活剂。